CLINICAL_TRIALS
trial_result
· 2017-10-05
Clinical Trial Update: Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer [Phase 2]
Summary
Phase 2 trial evaluating radiolabeled monoclonal antibody HuJ591-GS (177Lu-J591) in metastatic prostate cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-10-05